Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Minoxidil may help treat myelodysplastic syndrome without harming normal blood cell production.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Mesotherapy is a minimally invasive treatment with potential benefits and risks, requiring standardized practices and further investigation.

Multitarget drugs are needed to better treat complex diseases.

Inhibiting mTORC2 can reduce DNA repair and increase cancer cell death, suggesting potential for targeted brain cancer treatments.

Bubble-based systems show promise for precise, targeted drug delivery and diagnosis, especially in cancer treatment.

The combination treatment showed a higher response rate but no significant survival benefits.

M30 is a promising treatment for preventing hair loss during chemotherapy.

Mesotherapy uses small injections to improve skin, reduce fat, and treat hair loss effectively and quickly.

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.

Some new drugs show potential for treating blood cancers but have serious side effects and need more research.

Amivantamab treatment often causes skin issues that can affect quality of life and treatment continuation.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

Microneedles offer a promising, painless, and efficient way to deliver vaccines and therapies directly to the skin.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

Immunochemotherapy successfully treated neutropenia in a patient with Waldenström's macroglobulinemia.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

More research is needed to understand and treat morphea effectively.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Treating acute myeloid leukemia is challenging, especially in older adults, despite some advancements.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

A new patch can deliver stable antibodies over time for potential HIV treatment.